Robert Kesterson, PhD — CRISPRS & Gene Editing: Laboratory Use & Clinical Future (SERN/SERGG 2017)
Invited Speaker: Robert A. Kesterson, PhD – UAB “CRISPRs & Gene Editing: Laboratory Use & Clinical Future”
Meg Comeau, MHA — State Statutes and Legislation Related to Coverage of Dietary Treatments of Heritable Disorders (SERN/SERGG 2017)
Keynote Address: “State Statutes and Legislation Related to Coverage of Dietary Treatments of Heritable Disorders” Meg Comeau, MHA, Catalyst Center, Boston University School of Public Health
Emily Lisi, MS, CGC — The Current Status of Direct-to-Consumer Genetic Testing (SERN/SERGG 2017)
Invited Speaker: Emily Lisi, MS, CGC – Mayo Clinic “The Current Status of Direct-to-Consumer Genetic Testing”
Elizabeth Krupinski, PhD — Vision for Telemedicine (SERN/SERGG 2017)
“Vision for Telemedicine” Elizabeth A. Krupinski, PhD, Emory University School of Medicine
Kirk L. Pappan, PhD — Using Clinical Metabolomics to Screen for Inborn Errors of Metabolism (SERN/SERGG 2017)
Dr. Pappan presents, “Using Clinical Metabolomics to Screen for Inborn Errors of Metabolism”
Cindy L. Vnencak-Jones, PhD, FACMG — Precision Medicine for the Right Drug at the Right Dose on the First Time (SERN/SERGG 2017)
Invited Speaker: Cindy L Vnencak-Jones PhD – Vanderbilt University “Precision Medicine for the Right Drug at the Right Dose on the First Time”
Amy Yang, MD, FACMG — Newborn Screening for Pompe Disease: Lessons Learned from New York (SERN/SERGG 2017)
Dr. Amy Yang presents “Newborn Screening for Pompe Disease: Lessons Learned from New York”
Loren Pena, MD — New Gene Discovery and Other Insights from Diagnostic Evaluations in the Undiagnosed Diseases Network (SERN/SERGG 2017)
“New Gene Discovery and Other Insights from Diagnostic Evaluations in the Undiagnosed Diseases Network” by Loren Pena, MD, Undiagnosed Disease Network, Duke University.